Page last updated: 2024-08-22

isopentenyladenosine and Astrocytoma, Grade IV

isopentenyladenosine has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Avilia, G; Bifulco, M; Caiazzo, P; Chiariotti, L; Coppola, L; Corsaro, A; Della Monica, R; Florio, T; Gazzerro, P; Laezza, C; Navarra, G; Pagano, C; Pastorino, O; Torelli, G	1

Other Studies

1 other study(ies) available for isopentenyladenosine and Astrocytoma, Grade IV

Article	Year
N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity Inhibition. International journal of molecular sciences, 2021, Sep-29, Volume: 22, Issue:19 Topics: Antigens, CD; Cadherins; Catenins; Cell Line, Tumor; Glioblastoma; Humans; Isopentenyladenosine; Neovascularization, Pathologic; rhoA GTP-Binding Protein; Signal Transduction; src-Family Kinases	2021

Article

Year

N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity Inhibition.

International journal of molecular sciences, 2021, Sep-29, Volume: 22, Issue:19

Topics: Antigens, CD; Cadherins; Catenins; Cell Line, Tumor; Glioblastoma; Humans; Isopentenyladenosine; Neovascularization, Pathologic; rhoA GTP-Binding Protein; Signal Transduction; src-Family Kinases

2021